$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

$zvra Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924026474 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$3.695M	$4.449M
YoY Change	27.63%	-47.47%
Cost Of Revenue	$3.848M	$1.546M
YoY Change	2572.22%	128.36%
Gross Profit	-$153.0K	$2.903M
YoY Change	-105.56%	-62.75%
Gross Profit Margin	-4.14%	65.25%
Selling, General & Admin	$16.21M	$12.60M
YoY Change	178.58%	79.93%
% of Gross Profit		434.17%
Research & Development	$10.95M	$10.52M
YoY Change	-10.99%	41.54%
% of Gross Profit		362.42%
Depreciation & Amortization	$1.617M	$1.562M
YoY Change	2595.0%	1852.5%
% of Gross Profit		53.81%
Operating Expenses	$27.15M	$23.13M
YoY Change	49.89%	60.17%
Operating Profit	-$27.31M	-$23.80M
YoY Change	77.73%	258.09%
Interest Expense	-$1.173M	$3.940M
YoY Change	-420.49%	1900.0%
% of Operating Profit
Other Income/Expense, Net	-$5.919M	$3.940M
YoY Change	-495.66%	164.96%
Pretax Income	-$33.23M	-$19.86M
YoY Change	139.58%	284.94%
Income Tax	$0.00	$70.00K
% Of Pretax Income
Net Earnings	-$33.23M	-$19.93M
YoY Change	136.56%	291.92%
Net Earnings / Revenue	-899.19%	-447.85%
Basic Earnings Per Share	-$0.69	-$0.48
Diluted Earnings Per Share	-$0.70	-$0.48
COMMON SHARES
Basic Shares Outstanding	52.62M	41.85M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$89.38M	$49.26M
YoY Change	7.76%	-43.31%
Cash & Equivalents	$54.04M	$39.26M
Short-Term Investments	$35.34M	$9.998M
Other Short-Term Assets	$2.276M	$2.686M
YoY Change	-94.79%	34.3%
Inventory
Prepaid Expenses
Receivables	$7.790M	$8.947M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$99.44M	$60.89M
YoY Change	-27.42%	-41.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$607.0K	$678.0K
YoY Change	-5.45%	-1.6%
Goodwill	$4.700M	$4.700M
YoY Change
Intangibles	$70.61M	$66.15M
YoY Change
Long-Term Investments	$6.105M
YoY Change
Other Assets	$512.0K	$875.0K
YoY Change	245.95%	1550.94%
Total Long-Term Assets	$92.11M	$83.52M
YoY Change	4577.96%	3894.12%
TOTAL ASSETS
Total Short-Term Assets	$99.44M	$60.89M
Total Long-Term Assets	$92.11M	$83.52M
Total Assets	$191.6M	$144.4M
YoY Change	37.82%	36.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.46M	$20.45M
YoY Change	86.75%	94.78%
Accrued Expenses	$540.0K	$596.0K
YoY Change	35.0%	19.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$34.48M	$30.45M
YoY Change	58.8%	66.83%
LONG-TERM LIABILITIES
Long-Term Debt	$58.90M	$58.33M
YoY Change	51.81%	359.28%
Other Long-Term Liabilities	$5.521M	$6.638M
YoY Change	1214.52%	1994.01%
Total Long-Term Liabilities	$64.43M	$64.97M
YoY Change	15239.29%	20394.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.48M	$30.45M
Total Long-Term Liabilities	$64.43M	$64.97M
Total Liabilities	$121.8M	$111.9M
YoY Change	70.29%	202.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$469.6M	-$436.3M
YoY Change	38.33%	34.07%
Common Stock	$550.4M	$479.4M
YoY Change	31.63%	18.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.98M	$10.98M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$69.77M	$32.48M
YoY Change
Total Liabilities & Shareholders Equity	$191.6M	$144.4M
YoY Change	37.82%	36.86%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$33.23M	-$19.93M
YoY Change	136.56%	291.92%
Depreciation, Depletion And Amortization	$1.617M	$1.562M
YoY Change	2595.0%	1852.5%
Cash From Operating Activities	-$18.14M	-$19.11M
YoY Change	291.81%	119.64%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$31.35M	-$129.0K
YoY Change	-29.19%	-100.38%
Cash From Investing Activities	-$31.35M	-$129.0K
YoY Change	-29.48%	-100.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	64.77M	15.33M
YoY Change	146.63%	1513.68%
NET CHANGE
Cash From Operating Activities	-18.14M	-19.11M
Cash From Investing Activities	-31.35M	-129.0K
Cash From Financing Activities	64.77M	15.33M
Net Change In Cash	15.27M	-3.908M
YoY Change	-166.89%	-114.86%
FREE CASH FLOW
Cash From Operating Activities	-$18.14M	-$19.11M
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$18.14M	-$19.11M
YoY Change	277.94%	119.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43567156
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41991464
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43110360
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41534668
	us-gaap	Inventory Write Down InventoryWriteDown	3200000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36913
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5894398
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1180 Celebration Boulevard, Suite 103
	dei	Entity Address City Or Town EntityAddressCityOrTown	Celebration
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34747
	dei	City Area Code CityAreaCode	321
	dei	Local Phone Number LocalPhoneNumber	939-3416
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	ZVRA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52617789
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39260000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43049000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9998000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	24688000	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	8947000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	17377000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2686000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1824000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	60891000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	86938000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	10198000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9841000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	678000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	736000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	911000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	790000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	4701000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4701000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	66154000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	69227000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	875000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94000	usd
CY2024Q2	us-gaap	Assets Assets	144408000	usd
CY2023Q4	us-gaap	Assets Assets	172327000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	20452000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	28403000	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	37700000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	596000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	543000	usd
CY2024Q2	zvra	Discount And Rebate Liabilities Current DiscountAndRebateLiabilitiesCurrent	6768000	usd
CY2023Q4	zvra	Discount And Rebate Liabilities Current DiscountAndRebateLiabilitiesCurrent	4550000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2633000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2524000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	30449000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73720000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	58328000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5066000	usd
CY2024Q2	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	7856000	usd
CY2023Q4	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	16100000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	544000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	456000	usd
CY2024Q2	zvra	Discount And Rebate Liabilities Noncurrent DiscountAndRebateLiabilitiesNoncurrent	8115000	usd
CY2023Q4	zvra	Discount And Rebate Liabilities Noncurrent DiscountAndRebateLiabilitiesNoncurrent	7663000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6638000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7458000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	111930000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	110463000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	479361000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	472664000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	10983000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10983000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-436325000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399778000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	421000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-43000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	32478000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	61864000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	144408000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172327000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4449000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8470000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7874000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11646000	usd
CY2024Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3573000	usd
CY2023Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	677000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3748000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	802000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1546000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	0	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3074000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	0	usd
CY2024Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10521000	usd
CY2023Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7433000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	22798000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	16088000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12604000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6612000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22535000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13839000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	23125000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	14045000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	45333000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	29927000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-23795000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6252000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44281000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19083000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2110000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	197000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2845000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	379000	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5779000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2118000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9406000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-575000	usd
CY2024Q2	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	-1000	usd
CY2023Q2	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	-131000	usd
	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	26000	usd
	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	-327000	usd
CY2024Q2	zvra	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	270000	usd
CY2023Q2	zvra	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	1553000	usd
	zvra	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	1199000	usd
	zvra	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	2593000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3940000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3605000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7734000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3116000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19855000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2647000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-36547000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15967000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-74000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-177000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-19925000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2573000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36547000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15790000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41899087
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33898233
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41839582
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34180818
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19925000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2573000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36547000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15790000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	280000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-162000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	464000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-338000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	280000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-162000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	464000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-338000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19645000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2735000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36083000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16128000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-16622000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2119000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	56000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	71000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1146000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	184000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	48818000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-19925000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2632000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	193000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	480000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	280000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	32478000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13217000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	945000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3447000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	42000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-176000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	59267000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2573000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2151000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	165000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-162000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	58873000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36547000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15790000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4751000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3096000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	3219000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	710000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3124000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	157000	usd
	zvra	Fair Value Adjustment Of Warrants And Cvr Liability FairValueAdjustmentOfWarrantsAndCvrLiability	-9406000	usd
	zvra	Fair Value Adjustment Of Warrants And Cvr Liability FairValueAdjustmentOfWarrantsAndCvrLiability	-481000	usd
	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	26000	usd
	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	-327000	usd
	zvra	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	249000	usd
	zvra	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	67000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-188000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	138000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-8430000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5734000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	862000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	335000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3576000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-125000	usd
	zvra	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-298000	usd
	zvra	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-161000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8602000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2947000	usd
	zvra	Increase Decrease In Discount And Rebate Liabilities IncreaseDecreaseInDiscountAndRebateLiabilities	2670000	usd
	zvra	Increase Decrease In Discount And Rebate Liabilities IncreaseDecreaseInDiscountAndRebateLiabilities	3097000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-278000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-216000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	332000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	622000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35274000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12749000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	129000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	17467000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	14793000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	34000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14664000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16481000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	58990000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	12800000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2091000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	42700000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	13007000	usd
	zvra	Proceeds From Insurance Financing Arrangements ProceedsFromInsuranceFinancingArrangements	1082000	usd
	zvra	Proceeds From Insurance Financing Arrangements ProceedsFromInsuranceFinancingArrangements	1256000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	551000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	166000	usd
	zvra	Payments Of Principal On Insurance Financing Arrangements PaymentsOfPrincipalOnInsuranceFinancingArrangements	431000	usd
	zvra	Payments Of Principal On Insurance Financing Arrangements PaymentsOfPrincipalOnInsuranceFinancingArrangements	564000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3447000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1146000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16547000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2799000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	274000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-203000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3789000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	730000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43049000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65466000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39260000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	66196000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2135000	usd
	us-gaap	Interest Paid Net InterestPaidNet	261000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36500000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15800000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-436300000	usd
CY2024Q1	zvra	Common Stock Registered Shares CommonStockRegisteredShares	2269721
CY2024Q2	zvra	Common Stock Registered Maximum Offering Price CommonStockRegisteredMaximumOfferingPrice	350000000	usd
CY2021Q4	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><i><b>Use of Estimates</b></i></p> <p style="margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition, the useful lives of property and equipment, the recoverability of long-lived assets, the incremental borrowing rate for leases, and assumptions used for purposes of determining stock-based compensation, income taxes, the fair value of investments and the fair value of the warrant liabilities, contingent value right ("CVR") liabilities and discount and rebate liabilities, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p>
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	10000000	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	24700000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-100000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	600000	usd
CY2024Q2	us-gaap	Inventory Write Down InventoryWriteDown	3200000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4822000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2938000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3321000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1884000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2055000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5019000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	10198000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9841000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	938000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-148000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1218000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	82000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	58328000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	5066000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43567156
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43110360
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41991464
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41534668
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	20400031
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16695928
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41534668
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	9000
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	306826
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41850494
CY2024Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	97747
CY2024Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	41820
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1403
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41991464
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5483537
CY2023Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	1382489
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	7900000	usd
CY2023Q4	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	16100000	usd
CY2024Q2	zvra	Fair Value Adjustment Of Put Option Net Of Tax FairValueAdjustmentOfPutOptionNetOfTax	3600000	usd
	zvra	Fair Value Adjustment Of Put Option Net Of Tax FairValueAdjustmentOfPutOptionNetOfTax	8200000	usd
CY2023Q2	zvra	Fair Value Adjustment Of Put Option Net Of Tax FairValueAdjustmentOfPutOptionNetOfTax	2100000	usd
	zvra	Fair Value Adjustment Of Put Option Net Of Tax FairValueAdjustmentOfPutOptionNetOfTax	600000	usd
CY2021Q2	zvra	Employee Stock Purchase Plan Maximum Number Of Issuable Shares EmployeeStockPurchasePlanMaximumNumberOfIssuableShares	1500000
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	257575
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2632000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1103000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4751000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3096000	usd
	zvra	Class Of Warrant Or Right Liability Weighted Average Fair Value ClassOfWarrantOrRightLiabilityWeightedAverageFairValue	1.43
CY2023	zvra	Class Of Warrant Or Right Liability Weighted Average Fair Value ClassOfWarrantOrRightLiabilityWeightedAverageFairValue	2.94
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	16100000	usd
	zvra	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment	-8244000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7856000	usd
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15333032
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11280229
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15333032
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11280229
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-19925000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2573000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36547000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15790000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41899000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33898000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41840000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34181000
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
	zvra	Lessee Lease Option To Extend Maximum Term LesseeLeaseOptionToExtendMaximumTerm	P5Y
	zvra	Lessee Lease Option To Terminate Term LesseeLeaseOptionToTerminateTerm	P1Y
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	32000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	24000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	64000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2024Q2	zvra	Finance Lease Cost Total FinanceLeaseCostTotal	12000	usd
CY2023Q2	zvra	Finance Lease Cost Total FinanceLeaseCostTotal	32000	usd
	zvra	Finance Lease Cost Total FinanceLeaseCostTotal	24000	usd
	zvra	Finance Lease Cost Total FinanceLeaseCostTotal	64000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	118000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	114000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	211000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	227000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	59000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	55000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	118000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	110000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	0	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	13000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	13000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	26000	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	39000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	39000	usd
	us-gaap	Sublease Income SubleaseIncome	78000	usd
	us-gaap	Sublease Income SubleaseIncome	78000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	150000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	175000	usd
	us-gaap	Lease Cost LeaseCost	288000	usd
	us-gaap	Lease Cost LeaseCost	349000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	263000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	284000	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	118000	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	110000	usd
	us-gaap	Variable Lease Payment VariableLeasePayment	13000	usd
	us-gaap	Variable Lease Payment VariableLeasePayment	26000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	419000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	125000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	149000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	911000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	790000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	911000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	790000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	596000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	543000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	544000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	456000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1140000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	999000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P14Y3M18D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.076	pure
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	332000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	532000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	141000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	130000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	154000	usd
CY2024Q2	zvra	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q2	zvra	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	39000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1328000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	-0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	188000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1140000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	575000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	278000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	11000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	9376000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	35000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	209000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Approved Product Olpruva BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedApprovedProductOlpruva	68000000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	2000000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	85185000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses	10881000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Collaboration Funding BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredCollaborationFunding	1500000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities	175000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	12556000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	72629000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	8470000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	11646000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8211000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-28863000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	4700000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2000000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3100000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6200000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-24-026474-index-headers.html	Edgar Link	pending
0001437749-24-026474-index.html	Edgar Link	pending
0001437749-24-026474.txt	Edgar Link	pending
0001437749-24-026474-xbrl.zip	Edgar Link	pending
ex_676514.htm	Edgar Link	pending
ex_676515.htm	Edgar Link	pending
ex_676516.htm	Edgar Link	pending
ex_676517.htm	Edgar Link	pending
ex_709333.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zvra-20240630.xsd	Edgar Link	pending
zvra20240630_10q.htm	Edgar Link	pending
zvra-20240630_cal.xml	Edgar Link	unprocessable
zvra-20240630_def.xml	Edgar Link	unprocessable
zvra-20240630_lab.xml	Edgar Link	unprocessable
zvra-20240630_pre.xml	Edgar Link	unprocessable
zvra20240630_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

2024 Q3 Form 10-Q Financial Statement

#000143774924026474 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA ZEVRA THERAPEUTICS, INC. Stock $zvra

2024 Q3 Form 10-Q Financial Statement

#000143774924026474 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra